EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Meet the Contributors →

Latest News

  1. 1.

    Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More | National

  2. 2.

    Plexium Debuts With $28M and a New Take on Protein Degradation Drugs | San Diego

  3. 3.

    Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs | National

  4. 4.

    Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices | Boston

  5. 5.

    ArsenalBio Launches With $85M for “Programmable” T Cell Therapies | San Francisco

  6. 6.

    Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test | Indiana

Learn about the Xconomists →

Xconomist Forum

Featured Event

Xconomy Presents: What’s Next in Neuroscience Therapies

November 19, 2019

Deal of the Day

$85M

AresenalBio

People on the Move

Enzyvant Adds Compass’s Jeb Ledell as Its Chief Operating Officer

Pyxis Oncology Taps MedImmune’s Herbst as Chief Scientific Officer

More News

The Feed

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.